The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $57.45

Today's change0.00 0.00%
Updated July 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $57.45

Today's change0.00 0.00%
Updated July 26 4:00 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc closed at (U.S.)$57.45.

Over the last five days, shares have lost 10.09% and are down 6.13% for the last year to date. This security has underperformed the S&P 500 by 22.15% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $57.45
  • High--
  • Low--
  • Bid / Ask(U.S.) $56.00 / (U.S.) $58.00
  • YTD % change-6.13%
  • Volume1
  • Average volume (10-day)131,995
  • Average volume (1-month)96,458
  • Average volume (3-month)147,057
  • 52-week range(U.S.) $52.55 to (U.S.) $75.00
  • Beta1.08
  • Trailing P/E14.88×
  • P/E 1 year forward14.92×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.86
Updated July 26 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.47%

Based on its net profit margin of 9.47%, USANA Health Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 01, 201704/01/2017Dec 31, 201612/31/2016Oct 01, 201610/01/2016Jul 02, 201607/02/2016
Revenue255253254259
Total other revenue--------
Total revenue255253254259
Gross profit213207209213
Total cost of revenue43464546
Total operating expense222221218221
Selling / general / administrative180175173175
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income33323637
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax33323638
Income after tax21223026
Income tax, total1210612
Net income21223026
Total adjustments to net income--------
Net income before extra. items21223026
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items21223026
Inc. avail. to common incl. extra. items21223026
Diluted net income21223026
Dilution adjustment--------
Diluted weighted average shares25252525
Diluted EPS excluding extraordinary itemsvalue per share0.860.871.201.03
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.860.871.201.03